Editorial · 18 Jun 2020
Conference abstractPublished 8 Sep 2014
Personalized medicine in practice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Adverse drug reactions are often caused by genetic polymorphisms which alter a patient?s response to therapy. The FDA currently lists over 100 medications whose label contains information about either potential toxicity or lack of efficacy but to date this information has had little impact on treatment decisions. One barrier to adoption of pharmacogenetic testing is the clinician?s ability to interpret genetic test results. To alleviate this, the Clinical Pharmacogenetics Implementation Consortium (CPIC) was formed to create peer-reviewed and published guidelines for using genetic data to guide prescribing decisions. The guidelines provide specific prescribing recommendations along with grading levels of evidence. While this information fills an essential need, doctors still find it difficult to incorporate personalized prescribing into a typical 10 to 15 minute encounter. Translational Software has developed a platform for incorporating guidelines into clinical workflows. We are integrating with Laboratory Information Management Systems (LIMS) in order to translate raw genetic information into actionable reports for physicians. For clinicians with Electronic Medical Records the platform provides formatted HL7 messages that contain reports and discrete genetic results. This data can then be used to provide guidance for new prescriptions through an access in the EMR. The goal of these products is to make both pharmacogenetic testing and test interpretation more accessible by efficiently delivering them within the clinical environment.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2015
Implications of basic research in clinical practice: toward a personalized medicine in T-cell Acute Lymphoblastic Leukemia (T-ALL)
Mini review · 29 Jun 2024
Genomics in Clinical Practice: Realizing the Promise of Personalized Healthcare
Conference abstract · 15 Jul 2013
Practicing precision surgical pathology to explore clinically meaningful biomarkers for personalized oncology
Opinion · 30 Jun 2026
Next-generation Sequencing: Revolutionizing Clinical Genomics and Personalized Medicine
More from this journal
The newest in Molecular and Genetic Medicine.
Short communication · 29 Dec 2025
Chromatin Remodeling: Cancer, Development, and Therapeutics
Brief report · 29 Dec 2025
Multi-Omics: Accelerating Biomarker Discovery and Disease Insights
Short communication · 29 Dec 2025
RNA Editing: a Role in Health and Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular and Genetic Medicine
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Donald Rule”

